Variable change in renal function by hypertonic saline
- PMID: 24892021
- PMCID: PMC4038814
- DOI: 10.5492/wjccm.v3.i2.61
Variable change in renal function by hypertonic saline
Abstract
Aim: To investigate the effects of hypertonic saline in the neurocritical care population.
Methods: We retrospectively reviewed our hospital's use of hypertonic saline (HS) since March of 2005, and prospectively since October 2010. Comparisons were made between admission diagnoses, creatinine change (Cr), and HS formulation (3% NaCl, 3% NaCl/sodium acetate mix, and 23.4% NaCl) to patients receiving normal saline or lactated ringers. The patients (n = 1329) of the retrospective portion were identified. The data presented represents the first 230 patients with data.
Results: Significant differences in Acute Physiology and Chronic Health Evaluation II scores and Glasgow Coma Scale scores occurred between different saline formulations. No significant correlation of Cl(-) or Na(+) with Cr, nor with saline types, occurred. When dichotomized by diagnosis, significant correlations appear. Traumatic brain injury (TBI) patients demonstrated moderate correlation between Na(+) and Cr of 0.45. Stroke patients demonstrated weak correlations between Na(+) and Cr, and Cl(-) and Cr (0.19 for both). Patients receiving HS and not diagnosed with intracerebral hemorrhage, stroke, subarachnoid hemorrhage, or TBI demonstrated a weak but significant correlation between Cl(-) and Cr at 0.29.
Conclusion: Cr directly correlates with Na(+) or Cl(-) in stroke, Na(+) in TBI, and Cl(-) in other populations. Prospective comparison of HS and renal function is needed.
Keywords: Acute kidney injury; Cerebral edema; Critical care; Hypertonic saline solution; Sodium chloride.
Similar articles
-
Low-chloride versus high-chloride hypertonic solution for the treatment of subarachnoid hemorrhage-related complications (The ACETatE trial): study protocol for a pilot randomized controlled trial.Trials. 2018 Nov 14;19(1):628. doi: 10.1186/s13063-018-3007-7. Trials. 2018. PMID: 30428930 Free PMC article.
-
Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage-related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial.J Intensive Care. 2020 May 4;8:32. doi: 10.1186/s40560-020-00449-0. eCollection 2020. J Intensive Care. 2020. PMID: 32391156 Free PMC article.
-
Use of hypertonic saline/acetate infusion in treatment of cerebral edema in patients with head trauma: experience at a single center.J Trauma. 1999 Oct;47(4):659-65. doi: 10.1097/00005373-199910000-00009. J Trauma. 1999. PMID: 10528599
-
Hypertonic Solutions in Traumatic Brain Injury: A Systematic Review and Meta-Analysis.Asian J Neurosurg. 2019 Apr-Jun;14(2):382-391. doi: 10.4103/ajns.AJNS_8_19. Asian J Neurosurg. 2019. PMID: 31143250 Free PMC article. Review.
-
Hypertonic saline: first-line therapy for cerebral edema?J Neurol Sci. 2007 Oct 15;261(1-2):157-66. doi: 10.1016/j.jns.2007.04.048. Epub 2007 Jun 21. J Neurol Sci. 2007. PMID: 17585941 Review.
Cited by
-
Low-chloride versus high-chloride hypertonic solution for the treatment of subarachnoid hemorrhage-related complications (The ACETatE trial): study protocol for a pilot randomized controlled trial.Trials. 2018 Nov 14;19(1):628. doi: 10.1186/s13063-018-3007-7. Trials. 2018. PMID: 30428930 Free PMC article.
-
Cotreatment with Furosemide and Hypertonic Saline Decreases Serum Neutrophil Gelatinase-associated Lipocalin (NGAL) and Serum Creatinine Concentrations in Traumatic Brain Injury: A Randomized, Single-Blind Clinical Trial.Iran J Pharm Res. 2018 Summer;17(3):1130-1140. Iran J Pharm Res. 2018. PMID: 30127836 Free PMC article.
-
Intracerebral Hemorrhage: Perihemorrhagic Edema and Secondary Hematoma Expansion: From Bench Work to Ongoing Controversies.Front Neurol. 2016 Nov 21;7:210. doi: 10.3389/fneur.2016.00210. eCollection 2016. Front Neurol. 2016. PMID: 27917153 Free PMC article. Review.
-
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.Neurocrit Care. 2020 Jun;32(3):647-666. doi: 10.1007/s12028-020-00959-7. Neurocrit Care. 2020. PMID: 32227294 Free PMC article.
References
-
- Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379–1384. - PubMed
-
- Kollmar R, Staykov D, Dörfler A, Schellinger PD, Schwab S, Bardutzky J. Hypothermia reduces perihemorrhagic edema after intracerebral hemorrhage. Stroke. 2010;41:1684–1689. - PubMed
-
- Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med. 1986;314:953–958. - PubMed
-
- Ropper AH, Shafran B. Brain edema after stroke. Clinical syndrome and intracranial pressure. Arch Neurol. 1984;41:26–29. - PubMed
-
- Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke. 1999;30:1167–1173. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases